Dbv technologies to participate in the goldman sachs 45th annual global healthcare conference

ChÂtillon, france, june 5, 2024 dbv technologies to participate in the goldman sachs 45 th annual global healthcare conference dbv technologies (euronext: dbv – isin: fr0010417345 – nasdaq stock market: dbvt), a clinical-stage biopharmaceutical company focused on treatment options for food allergies and other immunologic conditions with significant unmet medical need, today announced that daniel tassÉ, chief executive officer, will participate in a fireside chat at the 45th annual goldman sachs global healthcare conference on monday, june 10th, at 8:00 am edt, as well as in one-on-one investor meetings. a live webcast of the presentation can be accessed here, and will also be available on the events section of company's investors website: https://dbv-technologies.com/investor-overview/events/ a replay will also be available on dbv technologies' website for 90 days after the event.
DBVT Ratings Summary
DBVT Quant Ranking